TORONTO, April 30, 2012 /PRNewswire via COMTEX/ —
During National Nursing Week, Canadians
will recognize and celebrate the important contributions nurses make
daily to patient care in Canada. The role nurses play in the prevention
and management of chronic hepatitis C, a potentially life-threatening
virus, provides a powerful example of their impact as supporter,
educator and counsellor.

Canadians living with chronic hepatitis C often fear the judgment of
others because the virus infecting them is often associated with
injection drug use. The reality is that people can contract the virus
through a number of different ways including, body piercings, tattoos,
blood transfusions or personal care items (razors).

Members of the Canadian Association of Hepatology Nurses (CAHN) build
trusted relationships with patients by not focusing on how the
hepatitis C virus was contracted, but rather on providing care and
support that is beneficial, respectful and can lead to a cure.

The road to a cure is a difficult journey for patients living with
chronic hepatitis C. While treatments can be very successful at getting
rid of the virus, the stigma associated with the disease often requires
patients to struggle through chemotherapy-like side effects in
isolation.

CAHN wants to shatter the stigma for those people living with chronic
hepatitis C by helping Canadians recognize that anyone, including
someone they know and love, could be living with this virus. Stigma
must not be a barrier to detection and treatment.

This National Nursing Week, celebrate the leadership provided by CAHN
nurses in the prevention and management of chronic hepatitis C.

What: Interview opportunities with nurses and individuals living with chronic
hepatitis C willing to share their stories

Who: Cheryl Dale, President of the Canadian Association of Hepatology
Nurses, CAHN members and individuals living with chronic hepatitis C

The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients. To read the entire study, click here Share This PageFollow Us … Continue reading → The post The study is aimed at assessing the safety and immunogenicity of HCV […]

The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of all DAA-based regimens in the clinical practice is different to what is … Continue reading → The post Real-life Security and Efficacy of DAA-based Therapy in 1,000 […]